Health
Results: 1669-1680 of 10165

Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals

Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)







